News for Healthier Living
Moffitt Study Unveils the Role of Gamma-Delta T Cells in Cancer Immunology
TAMPA, Fla. - A new study published in Cell Press reveals critical insights into the role of gamma-delta T cells across 33 cancer types, shedding light on their potential as clinical biomarkers and therapeutic targets in cancer treatment. Led by a team of researchers at Moffitt Cancer Center, this comprehensive analysis represents a significant advancement in the understanding of these unique immune cells and their implications for patient outcomes in cancer therapy.
October 4, 2024
January 6 2026January 5 2026January 4 2026January 3 2026January 2 2026January 1 2026December 31 2025December 30 2025December 29 2025December 28 2025December 27 2025December 26 2025December 24 2025December 23 2025
|
|
|
|
|